Cargando…
A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer
Detecting patients with dihydropyrimidine dehydrogenase (DPD) deficiency is becoming a major concern in clinical oncology. Monitoring physiologic plasma uracil and/or plasma uracil‐to‐dihydrouracil metabolic ratio is a common surrogate frequently used to determine DPD phenotype without direct measur...
Autores principales: | Marin, Clémence, Krache, Anis, Palmaro, Chloé, Lucas, Mathilde, Hilaire, Valentin, Ugdonne, Renée, De Victor, Bénédicte, Quaranta, Sylvie, Solas, Caroline, Lacarelle, Bruno, Ciccolini, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359930/ https://www.ncbi.nlm.nih.gov/pubmed/32058656 http://dx.doi.org/10.1111/cts.12762 |
Ejemplares similares
-
Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping
por: Royer, B., et al.
Publicado: (2023) -
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
por: Becher, François, et al.
Publicado: (2017) -
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
por: van Staveren, Maurice C., et al.
Publicado: (2011) -
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib
por: Ferrer, Florent, et al.
Publicado: (2021) -
Delayed Presentation of DPD Deficiency in Colorectal Cancer
por: Law, Lindsey, et al.
Publicado: (2014)